A Phase 4 interventional study of QUTENZA and Lidocaine in or Peripheral Nerve Injury (PNI) and Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN), sponsored by Astellas Pharma Inc. Completed at 20 sites in 7 countries. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2018-04-23.
Sponsored by Astellas Pharma Inc · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The Summary of product characteristics (SmPC) for QUTENZA advises that topical anaesthetic is applied prior to the application of QUTENZA. This is a multi-center, randomized, assessor-blinded study which will investigate the use of an oral analgesic as an alternative form of pre-treatment for QUTENZA.
All patients will be treated with QUTENZA for 60 minutes. Patients will be randomized to one of two arms- application of topical anaesthetic (lidocaine cream) or an oral analgesic (tramadol oral tables) prior to application of QUTENZA. Patients will be followed up for 7 days to monitor pain scores and tolerability.
90 studies on the registry are indexed under Peripheral Nerve Injuries; 24 are open to participants now.
This study's enrollment of 122 is above the median of 46 across 62 interventional studies indexed under Peripheral Nerve Injuries.
Browse Peripheral Nerve Injuries studies →Astellas Pharma Inc is the lead sponsor of 525 studies on the registry; 4 are open to participants now.
Of its 28 completed or terminated interventional studies of FDA-regulated products, 19 (68%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Tramadol prior to QUTENZA
Drug: QUTENZA · Drug: Tramadol
Lidocaine prior to QUTENZA
Drug: QUTENZA · Drug: Lidocaine
The proportion of subjects who tolerate QUTENZA treatment
A QUTENZA tolerant subject is defined as a subject receiving at least 90% of the intended patch duration.
Time frame: 60 minute application period
Duration of patch application
Time frame: 60 minutes
Change in pain scores from baseline to subsequent timepoints on the day of patch application
Time frame: 5, 25, 55, 85, 115 minutes on day of application and once a day on days 1, 2, 3
Proportion of subjects using pain medications and dose of pain medication(s) administered
Time frame: day 1-5
Subject rated tolerability score
Time frame: Baseline to end of study visit, day 7
Plan to share: Undecided
Ran from Jul 2011 to primary completion in Apr 2012, 9 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Lidocaine · Tramadol